Next flu pandemic: What to do until the vaccine arrives?November 13, 2006Experts believe the world is overdue for influenza pandemic. However, unless effective action against pandemic flu is taken now, we are in "dire straits," according to a paper published in the November 10 issue of Science. The articled titled, "Next Flu Pandemic: What to Do Until the Vaccine Arrives?," calls for research during the regular season flu season to better understand the effectiveness of non-pharmaceutical interventions such as social distancing, hand washing, face masks, and the like. "These are ironically similar to the measures used in 1918 to combat the greatest of all known influenza pandemics, but there's a lot we don't know about what may very well be our best defenses," says lead author Stephen Morse, PhD, associate professor of Clinical Epidemiology in the Department of Epidemiology at Columbia University's Mailman School of Public Health. According to Dr. Morse, unfortunately, there are no readily accessible compendia of best practices or even comprehensive databases of community epidemiologic data, which might help to design the most effective interventions. "As the weather turns cold and the regular flu season is upon us, there is an opportunity to prepare and move ahead with community studies and clinical trials in humans." How influenza is transmitted, from person to person, whether by large droplets or by fine particles, may seem to be a specialist issue, observes Dr. Morse, but "it has a direct bearing on how far apart people should position themselves to prevent infection and on whether inexpensive face masks might be useful."
Dr. Morse's coauthors are Richard L. Garwin, PhD, IBM Research Laboratories and Paula J. Olsiewski, PhD, of the Alfred P. Sloan Foundation. This spring, the authors organized a workshop on personal and workplace protective measures for pandemic influenza held at the Mailman School of Public Health and funded by the Alfred P. Sloan Foundation. "There are many basic things we don't know about how influenza is transmitted," said Dr. Garwin of IBM. "For example, it appears that a relatively low number of people catch the flu from another person. Breaking the transmission chain with non-pharmacological measures has proved challenging, but the prize is enormous." Often also neglected, according to the authors, are protective measures that fall between individual protection and the whole population - "the excluded middle"- such as buildings, facilities and smaller areas such as work places and homes. Examples might include improved air-handling systems, room-size fans, portable air-filtration systems, or physical barriers such as room dividers and doors. "We should systematically address knowledge gaps now during upcoming flu seasons rather than wait to empirically test measures ad hoc when the next pandemic is upon us," says Dr. Morse. Columbia University's Mailman School of Public Health | ||||||||||
|
Related Flu Pandemic News Articles European businesses not properly advised on how to prepare for flu pandemic A new report entitled Business Continuity Planning and Pandemic Influenza in Europe, published by the London School of Hygiene & Tropical Medicine (LSHTM), has found huge gaps and differences across Europe in the level of advice given to businesses to prepare for a possible influenza pandemic. 1 in 7 cases of bird flu could be prevented by closing schools in event of pandemic Closing schools in the event of a flu pandemic could slow the spread of the virus and prevent up to one in seven cases, according to a new study published today in the journal Nature. Study uncovers cause of flu epidemics The exchange of genetic material between two closely related strains of the influenza A virus may have caused the 1947 and 1951 human flu epidemics, according to biologists. MIT finds key to avian flu in humans MIT researchers have uncovered a critical difference between flu viruses that infect birds and humans, a discovery that could help scientists monitor the evolution of avian flu strains and aid in the development of vaccines against a deadly flu pandemic. If you don't want to fall ill this Christmas, then share a festive kiss but don't shake hands We've all heard people say 'I won't kiss you, I've got a cold'. But a report just published warns that we may be far more at risk of passing on an infection by shaking someone's hand than in sharing a kiss. Structure of influenza B virus protein gives clues to next pandemic Determining the structure of a protein called hemagglutinin on the surface of influenza B is giving researchers at Baylor College of Medicine and Rice University in Houston clues as to what kinds of mutations could spark the next flu pandemic. Report highlights inadequate pandemic planning as a threat to EU security A report to be published in an upcoming issue of the World Health Organisation (WHO) Bulletin will call for urgent attention to the politically sensitive issue of border control, and the need for coherent and robust national plans in the face of a catastrophic flu pandemic. Researchers identify key step bird flu virus takes to spread readily in humans Since it first appeared in Hong Kong in 1997, the H5N1 avian flu virus has been slowly evolving into a pathogen better equipped to infect humans. The final form of the virus, biomedical researchers fear, will be a highly pathogenic strain of influenza that spreads easily among humans. Michigan-CDC study supports value of social restrictions during influenza pandemics Although physicians have imposed quarantine orders since at least 1374, when the Port of Venice officially isolated foreigners and shippers for 40 days to keep out infectious scourges, there has been no definitive evidence that public health measures like quarantining the sick and isolating people after exposure to ill people would save lives during an influenza pandemic. Human antibodies protect mice from avian flu An international team of scientists, including researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, report using antibodies derived from immune cells from recent human survivors of H5N1 avian influenza to successfully treat H5N1-infected mice as well as protect them from an otherwise lethal dose of the virus. More Flu Pandemic News Articles |
||||||||||
|
||||||||||